Back to journals
Academic Journal

Journal of the American Academy of Child & Adolescent Psychiatry

1 Papers Indexed in Blossom

Data updated

Research Footprint

Journal of the American Academy of Child & Adolescent Psychiatry has 1 tracked paper indexed in Blossom (2026) from 9 authors, most often covering Esketamine and Ketamine, across Depressive Disorders, Suicidality and Adolescents.

Published Papers

Open Accessindividual

Effect of Esketamine on Depressive Symptoms in Adolescents with Major Depressive Disorder at Imminent Suicide Risk: A Randomized Psychoactive-Controlled Study

This double-blind Phase IIb trial (n=147) evaluated the efficacy, safety, and tolerability of esketamine nasal spray versus midazolam in reducing depressive (MDD) symptoms in adolescents at imminent risk for suicide (SI). The study finds that pooled doses of esketamine (56 and 84 mg) significantly reduce depressive symptoms at 24 hours, with common side effects including dizziness, nausea, and dissociation.

Published
Journal
Journal of the American Academy of Child & Adolescent Psychiatry
Authors
Kosik-Gonzalez, C., Chen, L. N., Lane, R., Bloch, M. H., DelBello, M., Moreno, C., Drevets, W. C., Canuso, C. M., Fu, D. J.

Quick Facts

Papers Indexed
1
Publisher
Elsevier
Website
Visit